“…Areas of effectiveness include the following: cardiology (Akgul et al, 2016); asthma (Brown, 2007;Hackman et al, 2000;Sutanto et al, 2016); pain in areas such as non-cardiac chest pain (NCCP) (Jones et al, 2005;Palsson & Whitehead, 2006), chronic pain (Jensen et al, 2010), amyotrophic lateral sclerosis (ALS) (also known as motor neurone disease MND or Lou Gehrig's disease) (Palmieri et al, 2012), migraine (Tastan & Turan, 2018;headaches (Hammond, 2007), multiple sclerosis (MS) (Dane, 1996;Elkins et al, 2012;Hosseinzadega et al, 2017); dental care (Clarke & Reynolds, 1991;De Jongh et al, 2005;Eitner et al, 2011;Fabian & Fabian, 1998); diabetes (Pilkington et al, 2007;Xu & Cardena, 2007); irritable bowel syndrome (Gonsalkorale, 2006;Gonsalkorale et al, 2002Gonsalkorale et al, , 2005Vlieger et al, 2007;Wilson et al, 2006); immunodeficiency (Setyadi et al, 2016;Solloway, 2004); oncology (Neron & Stephenson, 2007;Richardson et al, 2006Richardson et al, , 2007Syrjala et al, 1992); urology (Freeman & Baxby, 1982;Iglesias & Iglesias, 2008;Kandyba & Binik, 2003;); obstetrics and gynae (Brown & Hammond, 2007); and psycho-anaesthesia (Montgomery et al, 2000).…”